Safety of cilostazol in peripheral artery disease: a cohort from a primary healthcare electronic database

Overview of attention for article published in BMC Cardiovascular Disorders, May 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter: 5 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 18 Dimensions

Readers on

mendeley: 72 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 7,438 followers.

RT @IDIAPJGol: “Safety of cilostazol in peripheral artery disease: a cohort from a primary healthcare electronic database”. Real J, Serna M…

30 May 2018

Reply Repost Favourite

RT @IDIAPJGol: “Safety of cilostazol in peripheral artery disease: a cohort from a primary healthcare electronic database”. Real J, Serna M…

25 May 2018

Reply Repost Favourite

“Safety of cilostazol in peripheral artery disease: a cohort from a primary healthcare electronic database”. Real J, Serna MC, Giner-Soriano M, Forés R, Pera G, Ribes E, Alzamora M, Marsal JR, Heras A, Morros R. BMC Cardiovasc Disord https://t.co/SJ6knjPou

25 May 2018

Reply Repost Favourite

Safety of cilostazol in peripheral artery disease: a cohort from a primary healthcare electronic database #hvhebron #cardio https://t.co/S1SOFeu21J [Text complet] @BMC_series

14 May 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.